NMR analysis of a contaminant in heparin

Yakugaku Zasshi

Volumn 128, Issue 10, 2008, Pages 1513-1515

  Yamaguchi, Hideyuki ^a   Shinagawa, Mai ^a   Shimba, Nobuhisa ^a   Miyano, Hiroshi ^a   Suzuki, Eiichiro ^a  

^a AJINOMOTO CO INC   (Japan)

Author keywords

Contaminant; Heparin; NMR analysis

Indexed keywords

HEPARIN;

ARTICLE; DRUG CONTAMINATION; NUCLEAR MAGNETIC RESONANCE; OUTCOME ASSESSMENT;

CHEMISTRY, PHARMACEUTICAL; CHONDROITIN SULFATES; DRUG CONTAMINATION; HEPARIN; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 53249113575     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.128.1513     Document Type: Article

References (3)

1. Kishimoto T. K., Viswanathan K., Ganguly T., Elankumaran S., Smith S., Pelzer K., Lansing J. C., Sriranganathan N., Zhao G., Galcheva-Gargova Z., Al-Hakim A., Bailey G. S., Fraser B., Roy S., Rogers-Cotrone T., Buhse L., Whary M., Fox J., Nasr M., Pan G. J. D., Shriver Z., Langer R. S., Venkataraman G., Austen K. F., Woodcock J., Sasisekharan R., N. Engl. J. Med., 358, 2457-2467 (2008).
2. Guerrini M., Beccati D., Shriver Z., Naggi A., Viswanathan K., Bisio A., Capila I., Lansing J. C., Guglieri S., Fraser B., Al-Hakim A., Gunay N. S., Zhang Z., Robinson L., Buhse L., Nasr M., Woodcock J., Langer R., Venkataraman G., Linhardt R. J., Casu B., Torri G., Sasisekharan R., Nat. Biotechnol., 26, 669-675 (2008).
3. 〈http://www.fda.gov/cder/drug/infopage/heparin/default.htm〉